126,000 Shares in Select Medical Holdings Co. (NYSE:SEM) Acquired by Hussman Strategic Advisors Inc.

Hussman Strategic Advisors Inc. acquired a new position in Select Medical Holdings Co. (NYSE:SEM) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 126,000 shares of the health services provider’s stock, valued at approximately $2,375,000. Hussman Strategic Advisors Inc. owned 0.10% of Select Medical at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Quarry LP bought a new position in Select Medical in the 3rd quarter worth approximately $30,000. Wilmington Savings Fund Society FSB bought a new position in Select Medical in the 3rd quarter worth approximately $81,000. Mount Yale Investment Advisors LLC bought a new position in Select Medical in the 3rd quarter valued at $193,000. Vista Finance LLC bought a new position in Select Medical in the 4th quarter valued at $193,000. Finally, Virtu Financial LLC bought a new position in Select Medical in the 3rd quarter valued at $210,000. 89.48% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on SEM. UBS Group cut their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, January 3rd. StockNews.com downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, February 13th. Royal Bank of Canada raised their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Select Medical currently has a consensus rating of “Hold” and a consensus target price of $39.50.

Insider Activity

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 19.14% of the company’s stock.

Select Medical Stock Performance

Select Medical stock opened at $19.28 on Thursday. The firm’s fifty day moving average price is $19.14 and its 200-day moving average price is $28.14. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The stock has a market cap of $2.50 billion, a P/E ratio of 9.01, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45. Select Medical Holdings Co. has a fifty-two week low of $18.02 and a fifty-two week high of $40.98.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.